Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]

G. Tonini, C. Bizzarri, R. Bonfanti, M. Vanelli, F. Cerutti, E. Faleschini, F. Meschi, F. Prisco, E. Ciacco, M. Cappa, C. Torelli, V. Cauvin, S. Tumini, D. Iafusco, F. Barbetti

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2210-2213
Number of pages4
Issue number9
Publication statusPublished - Sept 2006

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this